pneumonia (CAP) and other acute respiratory tract infections (ARIs) in various age groups. 1 Lately, the prevalence of Chlamydia-associated ARIs decreased to less than 1.5% 2 , as a result of (i) changes in epidemiology of C. pneumoniae and (ii) increased specificity of new diagnostic molecular methods. Moreover, C. pneumoniae infection may remain undetected since clinicians may not screen the infected population. Indeed, Chlamydia pneumoniae has been recently identified as an agent of asthma exacerbation and has been associated with its severity, 3,4,5 thus reinforcing the importance to target these patients. In Lausanne, using a duplex real-time PCR, that detects C. pneumoniae and M. pneumoniae DNA 6 , we reported a 0.13% prevalence of C.
pneumoniae positive PCRs (2/1583) and identified one patient with C. pneumoniae-associated asthma, who recovered with antibiotics 7 . Below, we report a case series of C. pneumoniae respiratory infections in children.
From 10 th September to 5 th December 2013, 8 children were detected positive for C. pneumoniae from upper respiratory tract specimens (Table) . Of these, 5 were admitted for either acute asthma exacerbation or asthmatic bronchitis. All but two patients presented with chronic cough without fever nor systemic symptoms. These two patients presented a co-infection with either rhinovirus or M. pneumoniae and were admitted for severe respiratory distress in the intensive care unit, intubated and mechanically-ventilated, respectively for a community-acquired pneumonia (patient 7) and for a severe asthma exacerbation (patient 8). Both patients with severe clinical presentation were known for pre-existing asthma condition. All patients were successfully treated with a macrolide. Interestingly, C. pneumoniae infection was detected by chance in 7 patients as a result of the dual format of our PCR, because a Mycoplasma pneumoniae PCR was requested.
In conclusion, this report supports the role of C. pneumoniae in asthma exacerbation. Whether C.
pneumoniae-associated asthma may be cured with antibiotics or will also require steroids remains yet unknown and may vary from patient to patient. This case series underlines the importance of screening asthmatic children for C. pneumoniae. Moreover, our findings suggest that C. pneumoniae prevalence is likely underestimated and children with chronic cough, even in absence of fever, should be tested for C. pneumoniae. 
